Eli Lilly and Company - Strategy, SWOT and Corporate Finance Report

November 2023 | 55 pages | ID: EC7ADE73B57EN
MarketLine

Abstracts

Eli Lilly and Company %li%Strategy, SWOT and Corporate Finance Report

Summary

Eli Lilly and Company %li%Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Eli Lilly and Company (Eli Lilly or 'the company') is a pharmaceutical company that develops, discovers, manufactures, and sells pharmaceutical products. The company offers pharmaceutical products in the therapeutic areas of neuroscience, endocrinology, oncology, cardiovascular, and immunology. The company offers its products under the brands including Baqsimi, Basaglar, Cymbalta, Olumiant,Verzenio, cialis and Erbitux. The company distributes its products through wholesalers, on-line health care channels and sales representatives. Eli Lilly offers its products to pharmacies, hospitals, physicians, and other health care professionals. It has business presence in the US, Japan, Europe, and other countries. The company is headquartered in Indianapolis, Indiana, the US.

Scope

• Detailed information on Eli Lilly and Company required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Eli Lilly and Company in the form of a SWOT analysis
• An in-depth view of the business model of Eli Lilly and Company including a breakdown and examination of key business segments
• Intelligence on Eli Lilly and Company's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Eli Lilly and Company, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

• Gain understanding of Eli Lilly and Company and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Eli Lilly and Company as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Eli Lilly and Company's business structure, strategy and prospects.

Contents

Table of Contents
Company Snapshot
Eli Lilly and Company: Company Overview
Eli Lilly and Company: Overview and Key Facts
Eli Lilly and Company: Overview
Eli Lilly and Company: Key Facts
Eli Lilly and Company: Key Employees
Eli Lilly and Company: Key Employee Biographies
Eli Lilly and Company: Major Products and Services
Eli Lilly and Company: Management Statement
Eli Lilly and Company: Locations and Subsidiaries
Eli Lilly and Company: Key Competitors
Eli Lilly and Company: Company Analysis
Eli Lilly and Company: Business Description
Eli Lilly and Company: SWOT Analysis
Eli Lilly and Company: SWOT Overview
Eli Lilly and Company: Strengths
Eli Lilly and Company: Weaknesses
Eli Lilly and Company: Opportunities
Eli Lilly and Company: Threats
Eli Lilly and Company: Corporate Financial Deals Activity
Eli Lilly and Company: Financial Deals Overview
Eli Lilly and Company: Targets and Partners
Eli Lilly and Company: Top Deals 2019 - 2023YTD*
Eli Lilly and Company: Advisors
Eli Lilly and Company: Top Legal Advisors
Eli Lilly and Company: Top Financial Advisors
Eli Lilly and Company: Mergers and Acquisitions
Eli Lilly and Company: Corporate Venturing
Eli Lilly and Company: Capital Raising
Eli Lilly and Company: Partnership
Eli Lilly and Company: Divestments
Eli Lilly and Company: Recent Developments
Eli Lilly and Company: News and Events Summary
Eli Lilly and Company: Business Expansion
Eli Lilly and Company: Contracts
Eli Lilly and Company: Financial Performance
Eli Lilly and Company: Market Developments
Eli Lilly and Company: Regulatory and Legal Events
Eli Lilly and Company: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Eli Lilly and Company: Key Facts
Table 2: Eli Lilly and Company: Key Employees
Table 3: Eli Lilly and Company: Locations and Subsidiaries
Table 4: Eli Lilly and Company: Key Competitors
Table 5: Eli Lilly and Company: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Eli Lilly and Company: M&A Activity by Geography (TTM*)
Table 7: Eli Lilly and Company: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 8: Eli Lilly and Company: M&A Average Deal Size - Value (US$m)
Table 9: Eli Lilly and Company: Targets and Partners
Table 10: Eli Lilly and Company: Top Deals 2019 - 2023YTD*
Table 11: Eli Lilly and Company: Legal Advisor Ranking by Value (US$m)
Table 12: Eli Lilly and Company: Financial Advisor Ranking by Value (US$m)
Table 13: Eli Lilly and Company: M&A Volume and Value Trend (2019 - YTD*2023)
Table 14: Eli Lilly and Company: M&A Activity by Geography (2019 - YTD*2023)
Table 15: Eli Lilly and Company: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Table 16: Eli Lilly and Company: Corporate Venturing by Geography (2019 - YTD*2023)
Table 17: Eli Lilly and Company: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Table 18: Eli Lilly and Company: Capital Raising by Deal Type (2019 - YTD*2023)
Table 19: Eli Lilly and Company: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 20: Eli Lilly and Company: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 21: Eli Lilly and Company: Divestments Volume and Value Trend (2019 - YTD*2023)
Table 22: Eli Lilly and Company: Divestments by Geography (2019 - YTD*2023)
Table 23: Eli Lilly and Company: News and Events Summary
Table 24: Eli Lilly and Company: Business Expansion
Table 25: Eli Lilly and Company: Contracts
Table 26: Eli Lilly and Company: Financial Performance
Table 27: Eli Lilly and Company: Market Developments
Table 28: Eli Lilly and Company: Regulatory and Legal Events
Table 29: Eli Lilly and Company: Research & Development

List Of Figures

LIST OF FIGURES

Figure 1: Eli Lilly and Company: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Eli Lilly and Company: M&A Activity by Geography (TTM*)
Figure 3: Eli Lilly and Company: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 4: Eli Lilly and Company: M&A Average Deal Size - Value (US$m)
Figure 5: Eli Lilly and Company: M&A Volume and Value Trend (2019 - YTD*2023)
Figure 6: Eli Lilly and Company: M&A Activity by Geography (2019 - YTD*2023)
Figure 7: Eli Lilly and Company: Corporate Venturing Volume and Value Trend (2019 - YTD*2023)
Figure 8: Eli Lilly and Company: Corporate Venturing by Geography (2019 - YTD*2023)
Figure 9: Eli Lilly and Company: Capital Raising Volume and Value Trend (2019 - YTD*2023)
Figure 10: Eli Lilly and Company: Capital Raising by Deal Type (2019 - YTD*2023)
Figure 11: Eli Lilly and Company: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 12: Eli Lilly and Company: Partnership Trend by Deal Type (2019 - YTD*2023)
Figure 13: Eli Lilly and Company: Divestments Volume and Value Trend (2019 - YTD*2023)
Figure 14: Eli Lilly and Company: Divestments by Geography (2019 - YTD*2023)